Treatment of Myofascial Pain

Esenyel, Meltem; Caglar, Nil Sayiner; Aldemir, Tayfun

doi:10.1097/00002060-200001000-00011

Cited by 176 publications

(84 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The superiority of local injection or dry needling for the inactivation of MTrPs is controversial, [2][3][4][5][6][7][8] and hollow needles were used for dry needling in these studies. 2;6 Gunn suggests that the 'hollow needle' induces more tissue injury and is more painful than a 'pointed-tip needle '.…”

mentioning

confidence: 99%

Acupuncture Needling versus Lidocaine Injection of Trigger Points in Myofascial Pain Syndrome in Elderly Patients – a Randomised Trial

Choi

Park

et al. 2007

Acupunct Med

View full text Add to dashboard Cite

IntroductionMyofascial pain syndrome (MPS) is a common cause of musculoskeletal pain characterised by trigger points (MTrPs), that is tender loci in taut bands of skeletal muscle, limited range of motion in joints, referred pain and local twitch responses (LTRs) during mechanical stimulation of the MTrPs. 1 Inactivation of MTrPs is essential in managing MPS and several methods have been recommended. The treatments most commonly used for this purpose are dry needling of the MTrPs, injection treatments with local anaesthetics or saline, sprays, and stretching. 2According to the results of several studies, injection continues to be the most effective choice for treatment. The superiority of local injection or dry needling for the inactivation of MTrPs is controversial, [2][3][4][5][6][7][8] and hollow needles were used for dry needling in these studies. 2;6 Gunn suggests that the 'hollow needle' induces more tissue injury and is more painful than a 'pointed-tip needle '. 9 In this single-blinded randomised trial, we compared the efficacies and adverse events of acupuncture needling and 0.5% lidocaine injection of trigger points in myofascial pain syndrome. Method ParticipantsWe obtained retrospective ethical approval from the institutional review board of Inha University Hospital. We selected 40 subjects with chronic MPS of the upper trapezius from volunteers at four communitybased facilities; one further subject proved unable to complete the necessary forms. Subjects were selected on the basis of physical examination and interview, and signed informed consent was obtained. Participants were randomised into two groups by coin-toss: 1) ACU (acupuncture needling) group and 2) TPI (trigger point injection with 0.5% lidocaine) group.Inclusion criteria for the trial were 1) aged more than 60 years old; 2) complaining of chronic shoulder AbstractAim To compare the efficacy of acupuncture needling and 0.5% lidocaine injection of trigger points in myofascial pain syndrome of elderly patients. Methods Thirty nine participants with myofascial pain syndrome of one or both upper trapezius muscles were randomised to treatment with either acupuncture needling (n=18) or 0.5% lidocaine injection (n=21) at all the trigger points on days 0, 7 and 14, in a single-blinded study. Pain scores, range of neck movement, pressure pain intensity and depression were measured up to four weeks from the first treatment. Results Local twitch responses were elicited at least once in 94.9% of all subjects. Both groups improved, but there was no significant difference in reduction of pain in the two groups at any time point up to one month. Overall, the range of cervical movement improved in both groups, apart from extension in the acupuncture needling group. Changes in depression showed only trends. Conclusion There was no significant difference between acupuncture needling and 0.5% lidocaine injection of trigger points for treating myofascial pain syndrome in elderly patients.

show abstract

mentioning

confidence: 99%

Acupuncture Needling versus Lidocaine Injection of Trigger Points in Myofascial Pain Syndrome in Elderly Patients – a Randomised Trial

Choi

Park

et al. 2007

Acupunct Med

View full text Add to dashboard Cite

show abstract

“…The efficacy of TrP injection in terms of improvement in pain and depression has been well established in the literature [20][21][22]. Ay et al [20] compared the efficacy of TrP injection with lidocaine and dry needling on the pain and depression outcome.…”

Section: Discussionmentioning

confidence: 99%

A Comparative Study of Trigger Point Therapy with Local Anaesthetic (0.5 % Bupivacaine) Versus Combined Trigger Point Injection Therapy and Levosulpiride in the Management of Myofascial Pain Syndrome in the Orofacial Region

Gupta

Singh

Sethi

et al. 2015

J. Maxillofac. Oral Surg.

View full text Add to dashboard Cite

Aim To compare the efficacy of combined local anesthetic injection with 0.5 % bupivacaine and levosulpiride versus local anesthetic injection alone on outcome measures including levels of pain intensity and depression in the management of myofascial pain syndrome in orofacial region. Patients and Methods This was a prospective, randomized, controlled and open-label comparative clinical study. Seventy-four patients diagnosed to have myofascial pain syndrome and fulfilling the inclusion criteria were enrolled for the study. Patients were randomly assigned into 2 groups. Group A received local anesthetic injection (0.5 % bupivacaine) on trigger points and Group B received combined trigger point injection therapy and 50 mg of tablet Levosulpiride orally B.I.D. They were assessed for pain intensity and depression at baseline and at follow-up of 1, 4, 6 and 12 week intervals. Results The mean age of patients was 44.54 ? 15.977 years in group A and 39.97 ? 14.107 years in group B (P value = 0.2). Group A comprised of 25 females (67.567 %) and 12 males (32.432 %) while group B had 27 females (75 %) and 9 males (25 %). 70.27 % were diagnosed with moderate depression in group A and 75 % in group B. 18.91 % in group A and 19.44 % in group B were diagnosed with severe depression. When the VAS score and BDI score was compared at the follow-up intervals with the baseline scores in both treatment groups, the mean difference was highly significant at all the follow-up intervals. However when the relative efficacies of two interventions were compared between the two groups, improvement in pain was significant at all the follow-up intervals except the 1st week follow-up whereas the improvement in depression was non-significant at 1st and 4th week interval while it was highly significant at 6th and 12th week intervals. Conclusion The combined therapy with trigger point injection and levosulpiride as antidepressant significantly reduces pain and depression in the study subjects suffering from chronic myofascial pain with moderate to severe depression in the orofacial region.

show abstract

“…But there is still dilemma present as to whether chronic pain causes depression or depression causes pain [14]. Esenyel et al [15] reported that depression showed improvement by the treatment of MPS. Various trials have been done to evaluate the improvement in pain and depression with trigger point injection therapy with local anesthetic as well as dry needling.…”

Section: Discussionmentioning

confidence: 99%

A Comparative Pilot Study to Evaluate the Adjunctive Role of Levosulpride with Trigger Point Injection Therapy in the Management of Myofascial Pain Syndrome of Orofacial Region

Gupta

Singh

Sethi

et al. 2013

J. Maxillofac. Oral Surg.

View full text Add to dashboard Cite

Purpose To evaluate the effect of therapy with levosulpride combined with conventional trigger point injection therapy in terms of pain and depression in the chronic myofascial pain syndrome patients. Materials and Methods This was a comparative prospective study in which subjects with at least one trigger point and symptom duration of at least 3 months were recruited and randomized into two groups. Group A subjects received trigger point injections with 0.5 % bupivacaine and tablet levosulpride and group B received trigger point injections and a placebo. Subjects were assessed for pain with visual analog scale (VAS) and depression with Beck's depression inventory (BDI) at the follow-up periods of 1, 4, 6 and 12 weeks. The treatment effect was measured in terms of mean difference of BDI and VAS scores at various studied intervals from the baseline values. Results The sample was composed of 15 subjects with 8 in group A (6 females and 2 males, with a mean age of 41.88 ± 15.13 years, disease duration of 12.37 ± 16.11 months) and 7 in group B (6 females and 1 male, with a mean age of 43.86 ± 12.34 years, disease duration of 9.64 ± 9.34 months). The mean baseline VAS score and BDI score was 6.75 ± 1.03 in group A and 6.86 ± 1.06 in group B and 24.25 ± 10.20 in group A and 24.43 ± 11.16 in group B respectively. The mean difference of VAS scores at 12th week interval from the baseline values was highly significant. Although the mean difference of VAS scores at all the other intervals and mean difference of BDI scores at all the intervals was statistically nonsignificant, there was improvement in the mean differences at all the follow-up intervals in terms of both pain as well as depression. Conclusions The combined therapy with conventional trigger point injection and levosulpride as antidepressant significantly reduce pain and depression in the study subjects suffering from chronic myofascial pain with moderate to severe depression in the orofacial region.

show abstract

Treatment of Myofascial Pain

Abstract: Patients with myofascial pain syndrome had higher scores for anxiety than for depression. When combined with neck stretching exercises, ultrasound treatment and trigger point injections were found to be equally effective.

Cited by 176 publications

References 17 publications

Acupuncture Needling versus Lidocaine Injection of Trigger Points in Myofascial Pain Syndrome in Elderly Patients – a Randomised Trial

Acupuncture Needling versus Lidocaine Injection of Trigger Points in Myofascial Pain Syndrome in Elderly Patients – a Randomised Trial

A Comparative Study of Trigger Point Therapy with Local Anaesthetic (0.5 % Bupivacaine) Versus Combined Trigger Point Injection Therapy and Levosulpiride in the Management of Myofascial Pain Syndrome in the Orofacial Region

A Comparative Pilot Study to Evaluate the Adjunctive Role of Levosulpride with Trigger Point Injection Therapy in the Management of Myofascial Pain Syndrome of Orofacial Region

Contact Info

Product

Resources

About